Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial (RMD Open, 2022)

(untitled) - Baraliakos, X; Pournara, E; Gossec, L; Mease, P; White, R; O’Brien, E; Schulz, B; Marzo Ortega, H; Coates, LC